©2024 Stanford Medicine
Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department
Recruiting
Trial ID: NCT05151510
Purpose
The aim of this trial is to investigate the efficacy of trigger point injections with 1%
lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to
lidocaine patches 5%.
Official Title
A Randomized Controlled Study Comparing Trigger Point Injections With 1% Lidocaine Versus 5% Lidocaine Patch for Myofascial Pain in the Emergency Department
Stanford Investigator(s)
Jon B. Lee, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
- 18 years or older
- Diagnosed with myofascial pain of the posterior neck or back. *The diagnosis of
myofascial pain was based on established criteria of having a palpable taut band
(trigger point) that when depressed reproduced the patient's pain.
Exclusion Criteria:
- midline spinal tenderness
- evidence of radiculopathy
- pregnant
- have an allergy to lidocaine
- altered or deemed incapable of making informed consent
- had signs of infection or skin breakdown over the trigger point.
Intervention(s):
procedure: Trigger point injection with 1% lidocaine
drug: Lidocaine patch 5%
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305